Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines

Bibliographic Data

ID21515055
AuthorsRobert Steel (0000-0003-4879-2070, Rutgers, the State University of New Jersey), Lara Buchak (0000-0002-0232-4274, Princeton University), Nir Eyal (0000-0003-1056-6609, Rutgers, the State University of New Jersey, corresponding author)
Year2020
Volume46
Issue12
Pages808-812
Publication date2020-12-01
Open AccessYes
TypeARTICLE
VenueJournal of Medical Ethics (JOURNAL)
Journal identifiersISSN: 0306-6800 • E-ISSN: 1473-4257
PublisherBMJ (PUBLISHER • GB)
DOI10.1136/medethics-2020-106501
PMID32661074
OpenAlexW3041915940
LanguageEN
Citations received7
References cited24

To counter the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), some have proposed accelerating SARS-CoV-2 vaccine development through controlled human infection (or ‘challenge’) trials. These trials would involve the deliberate exposure of relatively few young, healthy volunteers to SARS-CoV-2. We defend this proposal against the charge that there is still too much uncertainty surrounding the risks of COVID-19 to responsibly run such a trial

2019-20 coronavirus outbreak · Betacoronavirus · Coronavirus · Coronavirus Infections · Data science · MEDLINE · Outbreak · Pandemic · Pathology · Political science · Computer Science · Law · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Viral Infections and Outbreaks Research · Virology

  • Vaccination, Risk, and Beneficence

    Open Access•Aksel Braanen Sterri•Ethical Theory and Moral Practice•2025

  • Exploring the ethics of tuberculosis human challenge models

    Open Access•Abie Rohrig, Josh Morrison et al.•Journal of Medical Ethics•2026

  • Uncertainty, error and informed consent to challenge trials of Covid-19 vaccines

    Open Access•Arnon Keren, Ori Lev•Journal of Medical Ethics•2020

  • Research ethics and public trust in vaccines

    Open Access•Nir Eyal•Journal of Medical Ethics•2024

  • Covid-19 controlled human infection studies

    Open Access•Kyungdo Lee, Nir Eyal•Journal of Medical Ethics•2021

  • Do coronavirus vaccine challenge trials have a distinctive generalisability problem

    Open Access•Nir Eyal, Tobias Gerhard•Journal of Medical Ethics•2022

  • YouTube and Religion during Covid-19

    Open Access•Achmad Sulfikar, Martin Tanis et al.•Journal of Religion and Health•2025

  • Risk and Rationality

    Lara Buchak, Lara Marie Buchak•Risk and rationality•2013

  • What Makes Clinical Research Ethical?

    Ezekiel J Emanuel•JAMA•2000

  • Estimates of the severity of coronavirus disease 2019

    Open Access•Robert Verity, Lucy Okell et al.•The Lancet Infectious Diseases•2020

  • The Routledge Handbook of the Ethics of Consent

    Andréas Müller, Peter Schaber•Routledge Handbook of the Ethics…•2018

  • Ethical guidelines for deliberately infecting volunteers with Covid-19

    Open Access•Adair D Richards•Journal of Medical Ethics•2020

  • What risks should be permissible in controlled human infection model studies

    Open Access•Ariella Binik•Bioethics•2020

  • Aids Activism and Coronavirus Vaccine Challenge Trials

    Open Access•Nir Eyal, Perry N Halkitis•AIDS and Behavior•2020

  • A Core Precautionary Principle

    Open Access•Stephen M Gardiner•Journal of Political Philosophy•2006

Citations per year1.17
Citation span2020 - 2026 (7)
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae